Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DCOOLTEWAH, Tenn., April 25, 2025 (GLOBE NEWSWIRE) -- Juvent, an innovator in clinically validated bone and musculoskeletal health solutions, debuted its revolutionary new supplement system HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Interdisciplinary Symposium today. HydroxyBMD3 AM/PM is a unique system formulated to address many of the issues surrounding menopause and andropause. Its clinically validated and patented ingredients improve bone, joint, skin, and cardiovascular health.
